Tarsus Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
  • Tarsus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.42M, a 41.2% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $25.9M, a 43.7% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.8M, a 47.3% increase from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 59.2% increase from 2021.
  • Tarsus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.46M, a 908% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $25.9M $7.42M +$2.17M +41.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $23.7M $7.48M +$2.29M +44.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $21.4M $5.52M +$1.61M +41.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $19.8M $5.48M +$1.81M +49.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $18M $5.25M +$1.67M +46.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $16.4M $5.19M +$1.66M +47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $14.7M $3.91M +$1.23M +46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $13.5M $3.67M +$1.49M +68.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $12M $3.58M +$1.46M +69.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $10.5M $3.53M +$738K +26.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $9.77M $2.67M +$1.31M +96.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $8.46M $2.18M +$5.74M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $2.72M $2.12M +$1.9M +850% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $823K $2.79M +$2.62M +1515% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$1.8M $1.36M -$2.64M -65.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $839K -$3.56M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $223K +$218K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $173K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $5K* Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.